S&PAA is leading the charge to advocate for people with schizophrenia and psychosis disorders as we shatter the barriers to treatment, survival and recovery.
We're proud to share that Chad, a member of S&PAA's Board of Directors, has been recognized with NAMI's 2026 Exemplary Psychiatrist Award, an honor awarded to just 13 psychiatrists nationwide this year.
Congrats, Chad!
https://t.co/H5kuUVL9Ga
#Psychiatry#MentalHealth
The U.S. Food and Drug Administration has approved new data for Caplyta (lumateperone) showing a reduced risk of relapse in people living with schizophrenia, a meaningful step forward in addressing one of the most destabilizing aspects of this illness.
https://t.co/rM9y7JA1zf
Washington, D.C. in spring means construction season. But this April, the most groundbreaking work on Capitol Hill wasn't in concrete — it was the foundation of the first-ever National Mental Illness Justice Center. #MentalHealthJustice
New research in Schizophrenia Research reframes schizophrenia as a neurodevelopmental syndrome rooted in early brain development.
Reclassify. Rename. Reshape.
How we define it shapes what follows.
https://t.co/x5P22dgux6
#Schizophrenia#Neurodevelopment#MentalHealth
Anne DeGeorge, S&PAA Director of Development, and Erica Tingler, S&PAA Director of Communications, attended the Health Policy Ball in support of Winston Fellowships and Scholarships–along with others leaders and policymakers committed to shaping the future of U.S. health policy.
S&PAA and TAC convene cross sector leaders April 23 in DC to shape founding principles for a National Mental Illness Justice Center. https://t.co/vNe5bPRFuN via @ein_news
On Feb 20, the FDA approved Bysanti (milsaperidone) for schizophrenia & acute manic/mixed episodes in bipolar I disorder in adults.
More treatment options matter for people with psychosis spectrum disorders & their families.
Details:
https://t.co/cZDZ8zRRM4
This Tuesday (Feb 10), S&PAA holds a briefing on Capitol Hill to illustrate where the true costs of schizophrenia fall—and how policy can shift billions from crisis response to effective care.
Event Details: https://t.co/W4rGRcu3Ys
#Schizophrenia#HealthPolicy#CapitolHill
A recent NYT op-ed tells a devastating but familiar story: families carrying impossible responsibility while watching loved ones fall into failing systems.
#SPAA#Schizophrenia#SeriousMentalIllness#MentalHealthPolicy
https://t.co/VvJDL14TfL
Our new peer-reviewed study, National and State Societal Costs of Schizophrenia in the United States in 2024, is published today in JAMA Psychiatry. Read the press release and watch our new video at https://t.co/fXh6xcBn5n
We’re pleased to welcome four new members to the S&PAA Board of Directors: Gary Labovich, Lauren Kennedy West, Raquelle I. Mesholam-Gately, and Ariel Snowden. Link to press release in comments.
#MentalHealth#Schizophrenia#Psychosis
President Trump is expected to direct agencies to begin reclassifying cannabis from Schedule I to Schedule III.
Public health—not commercial interest—must guide cannabis policy. Read SPAN’s letter to the DEA: https://t.co/gPwe8yPDP0
#SPAA#PublicHealth#CannabisPolicy
We know how to prevent tragedies linked to serious mental illness. The failure isn’t knowledge—it’s long-standing policy choices that underfund care, housing, and support. The question isn’t what to do. It’s when we’ll choose care before crisis.
#MentalHealthPolicy#PublicHealth
Finding housing for a loved one with SMI is so hard. Our new Housing Toolkit breaks the process into 4 parts:
1 Understanding needs
2 Housing options in your state
3 Financial pathways
4 Building a personalized plan
Explore: https://t.co/O9OrrjzTLK
#SPAA#Schizophrenia#Psychosis
📱 Help advance schizophrenia research with Dartmouth’s Jacobson Lab.
• Install a secure app
• 90 days of short surveys
• Earn up to $422
Eligibility: 18+, schizophrenia, on antipsychotics, U.S. resident, smartphone.
More: https://t.co/lIr3l8m89j
S&PAA is grateful for our community's generosity that's not only made of courage and personal sacrifice, but also your fierce hope.
All of us at the Schizophrenia & Psychosis Action Alliance wish you a happy Thanksgiving filled with hope and love.
#Thanksgiving#SPAA
A new KFF study shows 26% of unsheltered adults live with SMI—5x the general population. Another 26% live with chronic SUD. A system failing in real time.
Our Housing Toolkit helps families navigate care + housing options.
👉 https://t.co/O9OrrjzTLK
#SMI#HousingIsHealth#SPAA